Related Experiment Videos
[The uvea and crystalline lens: toxicity of new medications]
1Service d'Ophtalmologie, Hôpital Erasme, Université Libre de Bruxelles, Bruxelles. pierre.lefebvre@ulb.ac.be
Abstract:
The development of pharmaceutical industry brings us constantly new therapeutic agents. Whatever their delivery method, all these agents can potentially damage the ocular tissues. The WHO has established criteria to statue on the level of certainty between the drug and its adverse reaction. This article reviews the inflammatory lesions of the uvea and the lesions of the crystalline lens, which can be caused by the currently available medications. It develops the new pharmacologic agents and insists on the older ones sometimes already reported in the Bull. Soc. belge Ophtalmol in 1972, whose toxicity on the uvea or on the crystalline lens was then poorly known or rarely mentioned in the literature.
Insights
New medications can harm eye tissues, including the uvea and crystalline lens. This review examines drug-induced ocular inflammation and lens lesions, highlighting both new and older agents with potential toxicity.
Area of Science:
- Ophthalmology
- Pharmacology
- Toxicology
Context:
- The pharmaceutical industry continuously introduces new therapeutic agents with diverse delivery methods.
- All pharmaceutical agents possess the potential to induce ocular tissue damage.
- The World Health Organization (WHO) provides criteria for assessing the certainty of drug-adverse reaction relationships.
Purpose:
- To review inflammatory lesions of the uvea and crystalline lens induced by currently available medications.
- To discuss newly developed pharmacologic agents and re-evaluate older medications for ocular toxicity.
- To update the literature on the known or suspected toxicity of certain drugs on the uvea and crystalline lens.
Summary:
- This article systematically reviews ocular inflammatory lesions, specifically uveitis and crystalline lens damage, associated with pharmaceutical agents.
- It examines both novel and established medications, referencing historical reports of ocular toxicity from 1972.
- The review emphasizes the importance of recognizing and understanding drug-induced ocular side effects, particularly those affecting the uvea and lens.
Impact:
- Provides essential information for ophthalmologists and pharmacologists regarding drug-induced ocular toxicity.
- Contributes to patient safety by raising awareness of potential adverse reactions to medications.
- Facilitates informed prescribing decisions by detailing the ocular risks associated with various therapeutic agents.
Related Concept Videos
Glaucoma: Overview
Ophthalmic Drug Delivery Systems
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Photoreceptors and Visual Pathways
Angle Closure Glaucoma: Treatment
Drug Toxicity: Overview